/
ADIL
$4.39+$0.08 (+1.86%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$9.4M
2M shares
52-week range
$1.31 – $10.75
33% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Change$-2058.11
Adial Pharmaceuticals, Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.
www.adial.com- Employees
- 6
- IPO / List date
- Jul 27, 2018
- HQ
- CHARLOTTESVILLE, VA
Held by traders on TradeandTell
No one on the platform currently holds ADIL.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in ADIL as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2026-02-06 | 1-for-25reverse |
| 2023-08-07 | 1-for-25reverse |
Recent trades on TradeandTell
No one on the platform has traded ADIL yet.
